BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Skin cancer AND DDX6, P54, 1656, ENSG00000110367, HLR2, P26196, RCK, FLJ36338
10 results:

  • 1. Financial Toxicities Persist for cancer Survivors Irrespective of Current cancer Status: An Analysis of Medical Expenditure Panel Survey.
    Karim MA; Talluri R; Shastri SS; Kum HC; Shete S
    Cancer Res Commun; 2022 Oct; 2(10):1119-1128. PubMed ID: 36531523
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma.
    Khushalani NI; Vassallo M; Goldberg JD; Eroglu Z; Kim Y; Cao B; Ferguson R; Monson KR; Kirchhoff T; Amato CM; Burke P; Strange A; Monk E; Gibney GT; Kudchadkar R; Markowitz J; Brohl AS; Pavlick A; Richards A; Woods DM; Weber J
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36450385
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Relative and absolute cancer risks among Nordic kidney transplant recipients-a population-based study.
    Benoni H; Eloranta S; Dahle DO; Svensson MHS; Nordin A; Carstens J; Mjøen G; Helanterä I; Hellström V; Enblad G; Pukkala E; Sørensen SS; Lempinen M; Smedby KE
    Transpl Int; 2020 Dec; 33(12):1700-1710. PubMed ID: 32896035
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. "Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation".
    Wareham NE; Li Q; Sengeløv H; Da Cunha-Bang C; Gustafsson F; Heilmann C; Perch M; Rasmussen A; Sørensen SS; Mocroft A; Lundgren JD
    J Cancer Res Clin Oncol; 2019 Dec; 145(12):3125-3135. PubMed ID: 31587105
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Analysis of somatic mutations identifies signs of selection during in vitro aging of primary dermal fibroblasts.
    Narisu N; Rothwell R; Vrtačnik P; Rodríguez S; Didion J; Zöllner S; Erdos MR; Collins FS; Eriksson M
    Aging Cell; 2019 Dec; 18(6):e13010. PubMed ID: 31385397
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Melanoma inhibitory activity promotes melanoma development through activation of YBX1.
    Schmid R; Meyer K; Spang R; Schittek B; Bosserhoff AK
    Pigment Cell Melanoma Res; 2013 Sep; 26(5):685-96. PubMed ID: 23672612
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. p54nrb is a new regulator of progression of malignant melanoma.
    Schiffner S; Zimara N; Schmid R; Bosserhoff AK
    Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Ovine squamous cell carcinoma: immunocharacterisation of neoplastic cells and peritumoural cellular infiltrate.
    Pérez J; Méndez A; de Lara FC; Martín MP; Mozos E
    Res Vet Sci; 1997; 63(1):43-7. PubMed ID: 9368955
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Diet and risk of cutaneous malignant melanoma: a prospective study of 50,757 Norwegian men and women.
    Veierød MB; Thelle DS; Laake P
    Int J Cancer; 1997 May; 71(4):600-4. PubMed ID: 9178814
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Absence of cytokeratin 8 and inconsistent expression of cytokeratins 7 and 19 in human basal cell carcinoma.
    Habets JM; Tank B; Vuzevski VD; Brevé J; Stolz E; van Joost T
    Anticancer Res; 1988; 8(4):611-6. PubMed ID: 2460019
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.